Sequoia, Greenoaks Lead Isomorphic Lab’s $5 Billion Funding Round
Alphabet Inc. subsidiary Isomorphic Labs has secured $5 billion in a new funding round led by Sequoia and Greenoaks. The company specializes in using artificial intelligence to design pharmaceutical compounds, marking a significant investment in the intersection of machine learning and drug discovery.
Covered by 3 sources
- BBloomberg Technology↗Rebecca Torrence and Shirin Ghaffary5d ago
- TThe Decoder↗Maximilian Schreiner4d ago
- TTechCrunch AI↗Ram Iyer4d ago